Zhejiang Starry Pharmaceutical (603520)

Zhejiang Starry Pharmaceutical (603520)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


Zhejiang Starry Pharmaceutical Co., Ltd. is principally engaged in the research and development (R&D), production and sales of X-ray contrast medium, quinolone antimicrobial agents and other drugs’ pharmaceutical raw materials and intermediates. The X-ray contrast medium’s major product is iohexol active pharmaceutical ingredient. Quinolone antimicrobial agents’ major products are levofloxacin hydrochloride active pharmaceutical ingredient and levofloxacin hemihydrates active pharmaceutical ingredient.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner